Table 1.
Characteristics of the study participants
| Patient characteristics | HR (95% CI) | ||
|---|---|---|---|
| Age, years, median (range) | 74 (62–86) | 1.01 (0.95–1.07) | |
| Sex | Male/female | 21/7 | 2.81 (0.76–10.28) |
| PS | 0–2/3–4 | 21/10 | 2.49 (0.61–10.10) |
| Borrmann type | 1–3/4 and others | 24/7 | 0.73 (0.18–3.01) |
| Pathology | Adenocarcinoma | 30 | 1.02 (0.97–1.12) |
| Unknown malignancy | 1 | ||
| Metastasis | Yes/No 4/27 | 1.36 (0.39–4.68) | |
| Pre-treatment Hb level (g/dL), median (range) | 6.0 (4.7–9.7) | 0.89 (0.69–1.15) | |
| Transfusions, units | 8 (0–14) | 0.96 (0.63–1.45) | |
| Pre-RT treatment | APC | 25 | 0.77 (0.61–0.97) |
| Clipping | 11 | 0.81 (0.61–1.05) | |
| Bypass Op | 3 | 0.98 (0.93–1.01) | |
Hb, hemoglobin; Transfusion, packed red blood cell units transfused before radiotherapy; APC, argon plasma coagulation; clipping, endoscopic clipping; bypass op, gastrointestinal bypass operation; Pre-RT treatment, previous treatment before radiotherapy;
PS, Karnofsky performance status; HR, hazard ratio; CI, confidence interval